Oncothyreon (ONTY) – Major News
-
Oncothyreon (ONTY) Names New CEO
-
Oncothyreon (ONTY) Reports Q4 Loss of Per Share $0.10, Offers Guidance
-
Oncothyreon (ONTY) CEO Robert Kirkman Retires; Christopher Henney Named Interim CEO
-
Oncothyreon (ONTY) Presents Data from Trial of ONT-380 in HER2-Positive Breast Cancer Patients at SABCS
-
Oncothyreon (ONTY) Tops Q3 EPS by 4c
-
Oncothyreon (ONTY) Misses Q2 EPS by 3c
-
Oncothyreon (ONTY) Reports In-Line Q1 EPS
-
Oncothyreon (ONTY) Misses Q4 EPS by 21c
-
Oncothyreon (ONTY) Tops Q3 EPS by 2c
-
Oncothyreon, Inc. (ONTY) Tops Q2 EPS by 4c; Announces Acquisition of Alpine Biosciences
-
Oncothyreon, Inc. (ONTY) Misses Q1 EPS by 2c
-
Oncothyreon, Inc. (ONTY) Tops Q4 EPS by 1c
-
Oncothyreon, Inc. (ONTY) Posts Q3 Loss of 12c/Share
-
Oncothyreon, Inc. (ONTY) Misses Q2 EPS by 14c
-
Oncothyreon, Inc. (ONTY) Posts Q4 Loss of 12c/Share
-
Oncothyreon, Inc. (ONTY) Reports In-Line Q3 EPS
-
Oncothyreon, Inc. (ONTY) Posts Wider than Expected Q2 Loss of 15c/Share
-
Oncothyreon, Inc. (ONTY) Swings to Q1 Profit of 21c/Share
-
Oncothyreon (ONTY) Posts Wider than Expected Q4 Loss of 27c; Guides FY12 Expenses
-
Oncothyreon, Inc. (ONTY) Posts Surprise Q3 Profit
-
Oncothyreon, Inc. (ONTY) Posts Q2 Loss of 91c/Share
-
Oncothyreon, Inc. (ONTY) Reports Q1 EPS Loss of $0.24
-
Oncothyreon Inc (ONTY) Tops Q4 EPS by 3c; Revs Lighter
-
Oncothyreon Inc (ONTY) Posts Q1 Loss of 0.03, Beats Views
-
Oncothyreon (ONTY) Reports Worse-Than-Expected Q3 Loss of $0.24
-
Oncothyreon Inc. (ONTY) Reports Q2 EPS Results
-
Oncothyreon (ONTY) Reports Q4 EPS of $1.06; Comments on Outlook
-
Oncothyreon (ONTY) Reports Q3 Loss of $0.18, Beats by 3c
Back to ONTY Stock Lookup